Armistice Capital, LLC Reports 6.73% Stake in Orthofix Medical Inc. (OFIX)

On May 15, 2026, Armistice Capital, LLC and Steven Boyd filed a Schedule 13G/A with the SEC, disclosing a 6.73% ownership stake in Orthofix Medical Inc. (OFIX). The reporting persons beneficially own 2,700,000 shares of common stock as of the event date on March 31, 2026. Armistice Capital, LLC serves as the investment manager for the Armistice Capital Master Fund Ltd., which is the direct holder of the shares. Steven Boyd, as the managing member of Armistice Capital, LLC, may also be deemed to beneficially own these securities. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. This filing represents an increase in holdings compared to the previous reporting period where the filer held zero shares. The joint filing confirms shared voting and dispositive power over the reported 2,700,000 shares among the reporting persons.